19Jul/13

SIMPONI® ARIA™ (golimumab) for infusion Receives FDA Approval for … – PipelineReview.com (press release)

SIMPONI® ARIA™ (golimumab) for infusion Receives FDA Approval for
PipelineReview.com (press release)
Tell your doctor about all the medications you take including ORENCIA (abatacept), KINERET (anakinra), ACTEMRA (tocilizumab), RITUXAN (rituximab), or another TNF blocker, or if you are scheduled to or recently received a vaccine. People receiving 

and more »

19Jul/13

What Does Celgene Corporation (CELG)'s Failed Trial Mean for Investors? – Insider Monkey (blog)


Insider Monkey (blog)

What Does Celgene Corporation (CELG)’s Failed Trial Mean for Investors?
Insider Monkey (blog)
Biogen Idec Inc (NASDAQ:BIIB) and Roche offer rituximab as a first-line combination treatment, while Sanofi offers alemtuzumab as a second line treatment. Rituximab brought in $7.2 billion in sales in 2012 — making it one of the most successful drugs

and more »

19Jul/13

Desperate Buyers, Desperate Sellers Drive Global Black Market In Human Organs – Mintpress News

Desperate Buyers, Desperate Sellers Drive Global Black Market In Human Organs
Mintpress News
While the U.S. has legal organ donation and transplant procedures, those with the power of a large bank account are trying to remedy their health problems faster by obtaining an organ replacement themselves through the black market. “Organ

and more »